Journals / EurAsian Journal of Oral and Maxillofacial Surgery / 2026 / Volume: 4 Issue: 1

Osteonecrosis of the Jaw in a Young Patient: Beyond Medication-Related Causes

Genç Bir Hastada Çene Osteonekrozu: İlaç Dışı Nedenler

İpek Atak Seçen(GAZİ ÜNİVERSİTESİ, DİŞ HEKİMLİĞİ FAKÜLTESİ, TEMEL BİLİMLER BÖLÜMÜ, ORAL PATALOJİ ANABİLİM DALI)0000-0001-9663-5454
Berkay Mülayim(GAZİ ÜNİVERSİTESİ, DİŞ HEKİMLİĞİ FAKÜLTESİ, TEMEL BİLİMLER BÖLÜMÜ, ORAL PATALOJİ ANABİLİM DALI)0009-0000-1834-7430
Bilgesu Kurt(GAZİ ÜNİVERSİTESİ, DİŞ HEKİMLİĞİ FAKÜLTESİ, DİŞ HEKİMLİĞİ PR.)0000-0002-1944-3210
Emre Barış(GAZİ ÜNİVERSİTESİ, DİŞ HEKİMLİĞİ FAKÜLTESİ, TEMEL BİLİMLER BÖLÜMÜ, ORAL PATALOJİ ANABİLİM DALI)0000-0001-5096-4279
Pages
—
Publication Date
2025-01-29
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The case emphasizes the importance of minimizing trauma during dental procedures to prevent osteonecrosis, even in younger patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Medication-Related Osteonecrosis of the Jaw (MRONJ) is commonly associated with pharmacological agents like bisphosphonates.
📊
Key Findings & Data:This case report describes osteonecrosis in a 26-year-old male patient who underwent simultaneous implant placement and surgical tooth extraction.
💡
Conclusion & Impact:The case emphasizes the importance of minimizing trauma during dental procedures to prevent osteonecrosis, even in younger patients.
🔬Design:Case Report
📍Scope:Comprehensive Sample
⚙️Variables:dental implant · MRONJ · osteonecrosis

Abstract

Medication-Related Osteonecrosis of the Jaw (MRONJ) is commonly associated with pharmacological agents like bisphosphonates. However, osteonecrosis can also develop due to other etiologies, including dental trauma and infections. This case report describes osteonecrosis in a 26-year-old male patient who underwent simultaneous implant placement and surgical tooth extraction. The absence of systemic diseases or medication history highlights the role of dental trauma and impaired healing in osteonecrosis development. Management included surgical debridement and antibiotic therapy, consistent with Stage 2 osteonecrosis guidelines. The case emphasizes the importance of minimizing trauma during dental procedures to prevent osteonecrosis, even in younger patients.

Özet

İlaca Bağlı Çene Osteonekrozu (MRONJ), genellikle bifosfonatlar gibi farmakolojik ajanlarla ilişkilendirilse de, dental travma ve enfeksiyonlar gibi diğer etiyolojik faktörlere bağlı olarak da gelişebilmektedir. Bu vaka raporu, eş zamanlı implant yerleştirilmesi ve cerrahi diş çekimi uygulanan 26 yaşındaki bir erkek hastada gelişen osteonekrozu ele almaktadır. Hastanın sistemik bir hastalık veya ilaç kullanım öyküsünün bulunmaması; osteonekroz gelişiminde dental travma ve bozulmuş iyileşme sürecinin etkisini ön plana çıkarmaktadır. Tedavi, Evre 2 osteonekroz kılavuzları doğrultusunda, cerrahi debridman ve antibiyotik uygulaması ile gerçekleştirilmiştir. Çıkarılan materyalin histopatolojik incelemesi, osteonekroz tanısını doğulamıştır. Bu vaka, genç hastalarda dahi osteonekrozu önlemek için dental işlemler sırasında travmayı en aza indirmenin önemine dikkat çekmektedir.

🔖

Cite This Article

Seçen, İ. A., Mülayim, B., Kurt, B., Barış, E. (2025). Osteonecrosis of the Jaw in a Young Patient: Beyond Medication-Related Causes. EurAsian Journal of Oral and Maxillofacial Surgery, Volume: 4 Issue: 1. https://ajindex.com/articles/1629632

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Kılınç, Y. (2024). İlaca Bağlı Çene Osteonekrozu. ADO Klinik Bilimler Dergisi, 13(2), 264-277.
  2. Anastasilakis AD, Pepe J, Napoli N, Palermo A, Magopoulos C, Khan AA, et al. Osteonecrosis of the jaw and antiresorptive agents in benign and malignant diseases: a critical review organized by the ECTS. J Clin Endocrinol Metab. 2022;107(5):1441-60.
  3. Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg. 2003;61(9):1115-7.
  4. Advisory Task Force on Bisphosphonate-Related Osteonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg. 2007;65:369-76.
  5. Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, et al. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw—2014 update. J Oral Maxillofac Surg. 2014;72(10):1938- 56.
  6. Bassir SH, El Kholy K, Chen CY, Lee KH, Intini G. Outcome of early dental implant placement versus other dental implant placement protocols: a systematic review and meta-analysis. J Periodontol. 2019 May;90(5):493-506.
  7. Dahiya M, Dhawan P, Rani S, Saxena V. Critical analysis of the effect of antiresorptive drugs on osteonecrosis associated with dental implants: an umbrella review. Cureus. 2024 Oct 15;16(10):e71506.
  8. Assouline-Dayan Y, Chang C, Greenspan A, Shoenfeld Y, Gershwin ME. Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum. 2002;32(2):94-124.
  9. Magremanne M, Picheca S, Reychler H. Etiologic diagnosis of jaw osteonecrosis, other than bisphosphonate and radiotherapy related osteonecrosis. Rev Stomatol Chir Maxillofac Chir Orale. 2014;115(1):45-50.
  10. de Molon RS, et al. OPG‐Fc but not zoledronic acid discontinuation reverses osteonecrosis of the jaws (ONJ) in mice. J Bone Miner Res. 2015;30(9):1627-40.